NEW YORK (GenomeWeb) – Bio-Rad Laboratories' former general counsel and executive vice president Sanford Wadler has filed a lawsuit against the firm alleging that he was fired due to his efforts to uncover wrongdoing at the company.

In a lawsuit filed on Wednesday with the US District Court for the Northern District of California, Wadler, a 20-year veteran of the firm, says Bio-Rad fired him when he refused to turn a blind eye to evidence of Foreign Corrupt Practices Act violations in China.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.